ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Rauscher Faces Flood Subcommittee, Unfriendly Obey

March 5, 1976

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

Radio Host, Physician Elmer Huerta Becomes American Cancer Society President.

November 9, 2007

Environmental Carcinogenesis Seen As Next Big Growth Field; NCA Hears Problems, Priorities

October 31, 1975